By a News Reporter-Staff News Editor at Cardiovascular Week -- Researchers detail new data in Cardiovascular Diseases. According to news originating from New Haven, Connecticut, by NewsRx correspondents, research stated, "Techniques for in vivo assessment of disease-related molecular changes are being developed for all forms of non-invasive cardiovascular imaging. The ability to evaluate tissue molecular or cellular phenotype in patients has the potential to not only improve diagnostic capabilities but to enhance clinical care either by detecting disease at an earlier stage when it is more amenable to therapy, or by guiding most appropriate therapies."
Our news journalists obtained a quote from the research from Yale University, "These new techniques also can be used in research programs in order to characterize pathophysiology and as a surrogate endpoint for therapeutic efficacy. The most common approach for molecular imaging involves the creation of novel-targeted contrast agents that are designed so that their kinetic properties are different in disease tissues. The main focus of this review is not to describe all the different molecular imaging approaches that have been developed, but rather to describe the status of the field and highlight some of the clinical and research applications that molecular imaging will likely provide meaningful benefit."
According to the news editors, the research concluded: "Specific target areas include assessment of atherosclerotic disease, tissue ischemia, and ventricular and vascular remodeling."
For more information on this research see: Molecular imaging in cardiovascular disease: Which methods, which diseases? Journal of Nuclear Cardiology, 2013;20(6):990-1001. Journal of Nuclear Cardiology can be contacted at: Springer, 233 Spring St, New York, NY 10013, USA. (Springer - www.springer.com; Journal of Nuclear Cardiology - www.springerlink.com/content/1071-3581/)
The news correspondents report that additional information may be obtained from J.R. Lindner, Yale University, Sch Med, Dept. of Med, Sect Cardiovasc Med, New Haven, CT 06510, United States (see also Cardiovascular Diseases).
Keywords for this news article include: New Haven, Cardiology, Connecticut, United States, Nanotechnology, Molecular Imaging, Emerging Technologies, Cardiovascular Diseases, North and Central America
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC